-
Broadening our in vitro toxicology portfolio: DILIscope – drug induced liver injury screening service package available!
Building on our ongoing R&D advancements, we’re excited to announce the […]
-
Fast turnaround early ADME in vitro screening available!
For our customers with small molecules in the hit-to-lead stage of […]
-
What do our customers say about us?
You may be aware that each year we initiate a feedback […]
-
New hepatotoxicity services available!
Address hepatotoxicity and drug induced liver injury (DILI) risks early on! […]
-
Maximized Value in ADME-Tox Research through continuous development of services
Drug discovery is an ever-evolving process; at Admescope, we are committed […]
-
NEW SERVICE: Oligonucleotide ADME/DMPK Characterization
We are excited to announce the expansion of our service portfolio […]
-
Are you curious to know what existing Admescope customers say about working with us?
The decision of which CRO to work with can have a […]
-
Are you looking for in vivo DMPK data to support your project?
In vivo characterization is critical at various stages of the drug […]
-
Don’t wait until it’s too late to consider drug-drug interactions: Enzyme inhibition and induction evaluation
Patients are often treated with multiple simultaneous medications, which generates a […]
-
Quantitative bioanalysis: your project, our team of experts!
High-quality bioanalytical capabilities are one of the cornerstones in ADME/DMPK research. […]
-
Admescope increases capacity and capability in high-quality service production through new investments
As summer draws to a close, the Admescope team has been […]
Feel free to contact us!
Curious to know more about what can we do for you? Get in touch and let’s start a conversation.
